Skip to main content
. 2020 Jan 13;2020(1):CD012643. doi: 10.1002/14651858.CD012643.pub3

Molnar 2011.

Notes Title: The value of interim 18F‐FDG PET‐CT in Hodgkin lymphoma.
(Conference abstract)
Aim

  • To summarise our experience with 18F‐FDG PET‐CT in HL


Study design

  • Retrospective, November 2006 to January 2010


Country/treatment centre(s)

  • Hungary (National Institute of Oncology, Budapest)


Number of included participants

  • 60


Inclusion criteria

  • Not reported


Exclusion criteria

  • Not reported


Treatment

  • ABVD or BEACOPPesc, with or without RT


Primary outcome measure(s)

  • Prognostic value